Farringdon Capital’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,418
Closed -$14.5K 541
2025
Q1
$14.5K Buy
+1,418
New +$14.5K 0.01% 326